VAXCONSULT
ActiveSummary
VAXCONSULT has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €268k and a net result of €128k. Its solvency ranks better than 70% of 31694 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.7% (low).
Checked score
Score 2025
90
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100=
Growth52
Track record82
Bankruptcy probability, 12 months
0.7%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €24k at 30 days only on tighter terms
Liquidity ample (current ratio 3.97 against 4.75 in 2024; short-term debt: 25.2% and cash: 71.6% of total assets), and 25.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 70
Relative position
BE, all sectors
reference
Sector 70
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
74.8%
Return on assets
35.6%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-08-2026, 27 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 2 filingsDeviation from the deadline
2025
27 d late
2024
31 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€268k▲ 80.4%
2024 · €149k
2024: €149k
2024 → 2025
Total assets
€359k▲ 90.3%
2024 · €189k
2024: €189k
2024 → 2025
Net result
€128k▼ 8.1%
2024 · €139k
2024: €139k
2024 → 2025
Working capital
€268k▲ 80.4%
2024 · €149k
2024: €149k
2024 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20242025Trend
Equity€149k-€268k▲ 80.4%
Operating result€178k-€166k▼ 6.8%
Net result€139k-€128k▼ 8.1%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 7% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €359k
Equity
€268k ▲ 80.4%
Debt
€90k ▲ 127%
Debt's share of the balance-sheet total rises from 21.1% to 25.2%. Equity and debt are higher.
Key figures and ratios
Current ratio
3.97▼
2024 · 4.75
Debt to equity
0.34▲
2024 · 0.27
ROE
47.5%▼
2024 · 93.3%
ROA
35.6%▼
2024 · 73.6%
Debt ≤ 1 year
€90k▲
2024 · €40k
Income taxes
€39k▼
2024 · €40k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 31 lines
Balance sheet
Code20242025
Assets
Total assets20/58€189k€359k▲
Current assets29/58€189k€359k▲
Amounts receivable within one year40/41€8k€4k▼
Trade receivables40-€1k
Other amounts receivable41€8k€3k▼
Current investments50/53-€98k
Cash at bank and in hand54/58€181k€257k▲
Equity and liabilities
Total equity and liabilities10/49€189k€359k▲
Equity10/15€149k€268k▲
Contributions10/11€10k€10k=
Profit (loss) carried forward14€139k€258k▲
Amounts payable17/49€40k€90k▲
Amounts payable within one year42/48€40k€90k▲
Trade debts44-€306
Suppliers440/4-€306
Taxes, remuneration and social security45€40k€76k▲
Taxes450/3€40k€76k▲
Other amounts payable47/48-€14k
Income statement
Code20242025
Other operating charges640/8-€400
Gross operating margin9900€178k€167k▼
Operating profit (loss)9901€178k€166k▼
Financial income75/76B€941€3k▲
Recurring financial income75€941€3k▲
Financial charges65/66B€732€2k▲
Recurring financial charges65€732€2k▲
Profit (loss) for the period before taxes9903€179k€167k▼
Income taxes67/77€40k€39k▼
Profit (loss) for the period9904€139k€128k▼
Profit (loss) for the period to be appropriated9905€139k€128k▼
Appropriation of the result
Profit (loss) to be appropriated9906€139k€258k▲
Profit (loss) brought forward from the previous period14P-€131k
The notes to these accounts (1 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
27-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 27 days late
2025
31-12
Financial
Equity above €200kEq €268k ▲80.4%
2 profitable years in a row build equity to €268k.
31-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Ukkel · 1 establishment unit since 2024
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Jacques Pasturlaan 1601180 UkkelGround area
780 m²
Building footprint
182 m²
Volume, LiDAR
1,301 m³
Parcel 21614H0056/02S064, Brussels · tallest building 9.4 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
VAXCONSULT
since 20242.365.096.065
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21614H0056/02S064 | Brussels | 780 m² | 1 · 182 m² | 9.4 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
699400LA7USB73ZFF696
Similar companies · same sector, comparable size
@BPF
BE 0760.638.564
Gent · Eq €268,454
Blumanati
BE 0797.733.839
Schaarbeek · Eq €268,473
Freewood Consulting
BE 0832.379.071
Staden · Eq €268,440
ADvertising - an ADDitional value
BE 0891.375.263
Brugge · Eq €268,492
ANNEXIS
BE 0642.668.451
Beveren-Kruibeke-Zwijndrecht · Eq €268,412
Of 82,562 companies in sector 70200 we hold annual accounts for 52,574. 38,660 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded20-06-2024
Fiscal year end31-12
Activities, NACEBEL 2025
70200Business and other management consultancy
72101Research and development on biotechnology
Sources
Crossroads Bank for EnterprisesNational Bank · 2 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.